NZ Hepatitis Research Review Issue 21

In this issue:

HLA-B haplotypes hasten liver fibrosis in HIV/HCV
8-week DAA regimen: high SVR12 rates in HCV GT1/3
Ledipasvir-sofosbuvir + ribavirin: high SVR12 rates in advanced liver disease
Use nucleos(t)ide analogues following RFA for HCC
Risk of HCC after HCV cure
Discontinuing oral antivirals in chronic HBV
Acute HEV rare in acute liver failure
Treating GT3 HCV infection with advanced liver disease
HCV reinfection in PWID after earlier SVR
Nocturnal hypoxia and NAFLD

Please login below to download this issue (PDF)